Mycoplasma diagnostics is a class of medical tests or examination conducted to evaluate nucleic acids or proteins at a molecular level. This aids in the early detection of mycoplasma contaminations in samples. Mycoplasma diagnostics is considered as a rapidly evolving and fast growing segment in the in-vitro diagnostic industry. Usually, usage of molecular diagnostics was limited due to necessity of vastly skilled specialists and high cost of tests.
Based on product, the global mycoplasma diagnostics market can be segmented into kits & reagents, instruments, and software & services. Of these, the kits & reagents segment dominated the market in 2016 and is expected to hold on to its lead through the forecast period. However, growth witnessed in the software & services segment is forecast to be higher in the coming years. The rising demand for automation in pharma, dianostics, and clinical sectors to realize the benefits of cost-effectiveness, will fuel application of mycoplasma diagnostics in these applications.
Market Analysis and Insights: Global Mycoplasma Diagnostics Market
The global Mycoplasma Diagnostics market size is projected to reach US$ 703.5 million by 2026, from US$ 660.6 million in 2020, at a CAGR of 6.0%% during 2021-2026.
Global Mycoplasma Diagnostics Scope and Market Size
Mycoplasma Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Mycoplasma Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Agilent Technologies, Inc
Thermo Fisher Scientific Inc
PromoCell GmbH
Charles River Laboratories International, Inc
Merck KGaA
Lonza Group
Takara Bio Inc (Takara Holding Company Inc.)
Savyon Diagnostics
Tecan Trading AG (Tecan Group)
Sartorius Stedim BioOutsource Limited
American Type Culture Collection (ATCC)
F Hoffmann-La Roche
Mycoplasma Diagnostics Breakdown Data by Type
Kits & Reagents
Instruments
Software & Services
Mycoplasma Diagnostics Breakdown Data by Application
Hospitals
Diagnostic Laboratories
Clinics
Others
Based on product, the global mycoplasma diagnostics market can be segmented into kits & reagents, instruments, and software & services. Of these, the kits & reagents segment dominated the market in 2016 and is expected to hold on to its lead through the forecast period. However, growth witnessed in the software & services segment is forecast to be higher in the coming years. The rising demand for automation in pharma, dianostics, and clinical sectors to realize the benefits of cost-effectiveness, will fuel application of mycoplasma diagnostics in these applications.
Market Analysis and Insights: Global Mycoplasma Diagnostics Market
The global Mycoplasma Diagnostics market size is projected to reach US$ 703.5 million by 2026, from US$ 660.6 million in 2020, at a CAGR of 6.0%% during 2021-2026.
Global Mycoplasma Diagnostics Scope and Market Size
Mycoplasma Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Mycoplasma Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
Agilent Technologies, Inc
Thermo Fisher Scientific Inc
PromoCell GmbH
Charles River Laboratories International, Inc
Merck KGaA
Lonza Group
Takara Bio Inc (Takara Holding Company Inc.)
Savyon Diagnostics
Tecan Trading AG (Tecan Group)
Sartorius Stedim BioOutsource Limited
American Type Culture Collection (ATCC)
F Hoffmann-La Roche
Mycoplasma Diagnostics Breakdown Data by Type
Kits & Reagents
Instruments
Software & Services
Mycoplasma Diagnostics Breakdown Data by Application
Hospitals
Diagnostic Laboratories
Clinics
Others
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Mycoplasma Diagnostics Revenue
1.4 Market by Type
1.4.1 Global Mycoplasma Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Kits & Reagents
1.4.3 Instruments
1.4.4 Software & Services
1.5 Market by Application
1.5.1 Global Mycoplasma Diagnostics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Diagnostic Laboratories
1.5.4 Clinics
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Mycoplasma Diagnostics Market Perspective (2015-2026)
2.2 Global Mycoplasma Diagnostics Growth Trends by Regions
2.2.1 Mycoplasma Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Mycoplasma Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Mycoplasma Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Mycoplasma Diagnostics Market Growth Strategy
2.3.6 Primary Interviews with Key Mycoplasma Diagnostics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Mycoplasma Diagnostics Players by Market Size
3.1.1 Global Top Mycoplasma Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Mycoplasma Diagnostics Revenue Market Share by Players (2015-2020)
3.1.3 Global Mycoplasma Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Mycoplasma Diagnostics Market Concentration Ratio
3.2.1 Global Mycoplasma Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Mycoplasma Diagnostics Revenue in 2019
3.3 Mycoplasma Diagnostics Key Players Head office and Area Served
3.4 Key Players Mycoplasma Diagnostics Product Solution and Service
3.5 Date of Enter into Mycoplasma Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Mycoplasma Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Mycoplasma Diagnostics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Mycoplasma Diagnostics Market Size by Application (2015-2020)
5.2 Global Mycoplasma Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Mycoplasma Diagnostics Market Size (2015-2020)
6.2 Mycoplasma Diagnostics Key Players in North America (2019-2020)
6.3 North America Mycoplasma Diagnostics Market Size by Type (2015-2020)
6.4 North America Mycoplasma Diagnostics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Mycoplasma Diagnostics Market Size (2015-2020)
7.2 Mycoplasma Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Mycoplasma Diagnostics Market Size by Type (2015-2020)
7.4 Europe Mycoplasma Diagnostics Market Size by Application (2015-2020)
8 China
8.1 China Mycoplasma Diagnostics Market Size (2015-2020)
8.2 Mycoplasma Diagnostics Key Players in China (2019-2020)
8.3 China Mycoplasma Diagnostics Market Size by Type (2015-2020)
8.4 China Mycoplasma Diagnostics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Mycoplasma Diagnostics Market Size (2015-2020)
9.2 Mycoplasma Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Mycoplasma Diagnostics Market Size by Type (2015-2020)
9.4 Japan Mycoplasma Diagnostics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Mycoplasma Diagnostics Market Size (2015-2020)
10.2 Mycoplasma Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Mycoplasma Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Mycoplasma Diagnostics Market Size by Application (2015-2020)
11 India
11.1 India Mycoplasma Diagnostics Market Size (2015-2020)
11.2 Mycoplasma Diagnostics Key Players in India (2019-2020)
11.3 India Mycoplasma Diagnostics Market Size by Type (2015-2020)
11.4 India Mycoplasma Diagnostics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Mycoplasma Diagnostics Market Size (2015-2020)
12.2 Mycoplasma Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Mycoplasma Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Mycoplasma Diagnostics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Agilent Technologies, Inc
13.1.1 Agilent Technologies, Inc Company Details
13.1.2 Agilent Technologies, Inc Business Overview
13.1.3 Agilent Technologies, Inc Mycoplasma Diagnostics Introduction
13.1.4 Agilent Technologies, Inc Revenue in Mycoplasma Diagnostics Business (2015-2020))
13.1.5 Agilent Technologies, Inc Recent Development
13.2 Thermo Fisher Scientific Inc
13.2.1 Thermo Fisher Scientific Inc Company Details
13.2.2 Thermo Fisher Scientific Inc Business Overview
13.2.3 Thermo Fisher Scientific Inc Mycoplasma Diagnostics Introduction
13.2.4 Thermo Fisher Scientific Inc Revenue in Mycoplasma Diagnostics Business (2015-2020)
13.2.5 Thermo Fisher Scientific Inc Recent Development
13.3 PromoCell GmbH
13.3.1 PromoCell GmbH Company Details
13.3.2 PromoCell GmbH Business Overview
13.3.3 PromoCell GmbH Mycoplasma Diagnostics Introduction
13.3.4 PromoCell GmbH Revenue in Mycoplasma Diagnostics Business (2015-2020)
13.3.5 PromoCell GmbH Recent Development
13.4 Charles River Laboratories International, Inc
13.4.1 Charles River Laboratories International, Inc Company Details
13.4.2 Charles River Laboratories International, Inc Business Overview
13.4.3 Charles River Laboratories International, Inc Mycoplasma Diagnostics Introduction
13.4.4 Charles River Laboratories International, Inc Revenue in Mycoplasma Diagnostics Business (2015-2020)
13.4.5 Charles River Laboratories International, Inc Recent Development
13.5 Merck KGaA
13.5.1 Merck KGaA Company Details
13.5.2 Merck KGaA Business Overview
13.5.3 Merck KGaA Mycoplasma Diagnostics Introduction
13.5.4 Merck KGaA Revenue in Mycoplasma Diagnostics Business (2015-2020)
13.5.5 Merck KGaA Recent Development
13.6 Lonza Group
13.6.1 Lonza Group Company Details
13.6.2 Lonza Group Business Overview
13.6.3 Lonza Group Mycoplasma Diagnostics Introduction
13.6.4 Lonza Group Revenue in Mycoplasma Diagnostics Business (2015-2020)
13.6.5 Lonza Group Recent Development
13.7 Takara Bio Inc (Takara Holding Company Inc.)
13.7.1 Takara Bio Inc (Takara Holding Company Inc.) Company Details
13.7.2 Takara Bio Inc (Takara Holding Company Inc.) Business Overview
13.7.3 Takara Bio Inc (Takara Holding Company Inc.) Mycoplasma Diagnostics Introduction
13.7.4 Takara Bio Inc (Takara Holding Company Inc.) Revenue in Mycoplasma Diagnostics Business (2015-2020)
13.7.5 Takara Bio Inc (Takara Holding Company Inc.) Recent Development
13.8 Savyon Diagnostics
13.8.1 Savyon Diagnostics Company Details
13.8.2 Savyon Diagnostics Business Overview
13.8.3 Savyon Diagnostics Mycoplasma Diagnostics Introduction
13.8.4 Savyon Diagnostics Revenue in Mycoplasma Diagnostics Business (2015-2020)
13.8.5 Savyon Diagnostics Recent Development
13.9 Tecan Trading AG (Tecan Group)
13.9.1 Tecan Trading AG (Tecan Group) Company Details
13.9.2 Tecan Trading AG (Tecan Group) Business Overview
13.9.3 Tecan Trading AG (Tecan Group) Mycoplasma Diagnostics Introduction
13.9.4 Tecan Trading AG (Tecan Group) Revenue in Mycoplasma Diagnostics Business (2015-2020)
13.9.5 Tecan Trading AG (Tecan Group) Recent Development
13.10 Sartorius Stedim BioOutsource Limited
13.10.1 Sartorius Stedim BioOutsource Limited Company Details
13.10.2 Sartorius Stedim BioOutsource Limited Business Overview
13.10.3 Sartorius Stedim BioOutsource Limited Mycoplasma Diagnostics Introduction
13.10.4 Sartorius Stedim BioOutsource Limited Revenue in Mycoplasma Diagnostics Business (2015-2020)
13.10.5 Sartorius Stedim BioOutsource Limited Recent Development
13.11 American Type Culture Collection (ATCC)
10.11.1 American Type Culture Collection (ATCC) Company Details
10.11.2 American Type Culture Collection (ATCC) Business Overview
10.11.3 American Type Culture Collection (ATCC) Mycoplasma Diagnostics Introduction
10.11.4 American Type Culture Collection (ATCC) Revenue in Mycoplasma Diagnostics Business (2015-2020)
10.11.5 American Type Culture Collection (ATCC) Recent Development
13.12 F Hoffmann-La Roche
10.12.1 F Hoffmann-La Roche Company Details
10.12.2 F Hoffmann-La Roche Business Overview
10.12.3 F Hoffmann-La Roche Mycoplasma Diagnostics Introduction
10.12.4 F Hoffmann-La Roche Revenue in Mycoplasma Diagnostics Business (2015-2020)
10.12.5 F Hoffmann-La Roche Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Mycoplasma Diagnostics Revenue
1.4 Market by Type
1.4.1 Global Mycoplasma Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Kits & Reagents
1.4.3 Instruments
1.4.4 Software & Services
1.5 Market by Application
1.5.1 Global Mycoplasma Diagnostics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Diagnostic Laboratories
1.5.4 Clinics
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Mycoplasma Diagnostics Market Perspective (2015-2026)
2.2 Global Mycoplasma Diagnostics Growth Trends by Regions
2.2.1 Mycoplasma Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Mycoplasma Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Mycoplasma Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Mycoplasma Diagnostics Market Growth Strategy
2.3.6 Primary Interviews with Key Mycoplasma Diagnostics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Mycoplasma Diagnostics Players by Market Size
3.1.1 Global Top Mycoplasma Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Mycoplasma Diagnostics Revenue Market Share by Players (2015-2020)
3.1.3 Global Mycoplasma Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Mycoplasma Diagnostics Market Concentration Ratio
3.2.1 Global Mycoplasma Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Mycoplasma Diagnostics Revenue in 2019
3.3 Mycoplasma Diagnostics Key Players Head office and Area Served
3.4 Key Players Mycoplasma Diagnostics Product Solution and Service
3.5 Date of Enter into Mycoplasma Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Mycoplasma Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Mycoplasma Diagnostics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Mycoplasma Diagnostics Market Size by Application (2015-2020)
5.2 Global Mycoplasma Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Mycoplasma Diagnostics Market Size (2015-2020)
6.2 Mycoplasma Diagnostics Key Players in North America (2019-2020)
6.3 North America Mycoplasma Diagnostics Market Size by Type (2015-2020)
6.4 North America Mycoplasma Diagnostics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Mycoplasma Diagnostics Market Size (2015-2020)
7.2 Mycoplasma Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Mycoplasma Diagnostics Market Size by Type (2015-2020)
7.4 Europe Mycoplasma Diagnostics Market Size by Application (2015-2020)
8 China
8.1 China Mycoplasma Diagnostics Market Size (2015-2020)
8.2 Mycoplasma Diagnostics Key Players in China (2019-2020)
8.3 China Mycoplasma Diagnostics Market Size by Type (2015-2020)
8.4 China Mycoplasma Diagnostics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Mycoplasma Diagnostics Market Size (2015-2020)
9.2 Mycoplasma Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Mycoplasma Diagnostics Market Size by Type (2015-2020)
9.4 Japan Mycoplasma Diagnostics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Mycoplasma Diagnostics Market Size (2015-2020)
10.2 Mycoplasma Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Mycoplasma Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Mycoplasma Diagnostics Market Size by Application (2015-2020)
11 India
11.1 India Mycoplasma Diagnostics Market Size (2015-2020)
11.2 Mycoplasma Diagnostics Key Players in India (2019-2020)
11.3 India Mycoplasma Diagnostics Market Size by Type (2015-2020)
11.4 India Mycoplasma Diagnostics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Mycoplasma Diagnostics Market Size (2015-2020)
12.2 Mycoplasma Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Mycoplasma Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Mycoplasma Diagnostics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Agilent Technologies, Inc
13.1.1 Agilent Technologies, Inc Company Details
13.1.2 Agilent Technologies, Inc Business Overview
13.1.3 Agilent Technologies, Inc Mycoplasma Diagnostics Introduction
13.1.4 Agilent Technologies, Inc Revenue in Mycoplasma Diagnostics Business (2015-2020))
13.1.5 Agilent Technologies, Inc Recent Development
13.2 Thermo Fisher Scientific Inc
13.2.1 Thermo Fisher Scientific Inc Company Details
13.2.2 Thermo Fisher Scientific Inc Business Overview
13.2.3 Thermo Fisher Scientific Inc Mycoplasma Diagnostics Introduction
13.2.4 Thermo Fisher Scientific Inc Revenue in Mycoplasma Diagnostics Business (2015-2020)
13.2.5 Thermo Fisher Scientific Inc Recent Development
13.3 PromoCell GmbH
13.3.1 PromoCell GmbH Company Details
13.3.2 PromoCell GmbH Business Overview
13.3.3 PromoCell GmbH Mycoplasma Diagnostics Introduction
13.3.4 PromoCell GmbH Revenue in Mycoplasma Diagnostics Business (2015-2020)
13.3.5 PromoCell GmbH Recent Development
13.4 Charles River Laboratories International, Inc
13.4.1 Charles River Laboratories International, Inc Company Details
13.4.2 Charles River Laboratories International, Inc Business Overview
13.4.3 Charles River Laboratories International, Inc Mycoplasma Diagnostics Introduction
13.4.4 Charles River Laboratories International, Inc Revenue in Mycoplasma Diagnostics Business (2015-2020)
13.4.5 Charles River Laboratories International, Inc Recent Development
13.5 Merck KGaA
13.5.1 Merck KGaA Company Details
13.5.2 Merck KGaA Business Overview
13.5.3 Merck KGaA Mycoplasma Diagnostics Introduction
13.5.4 Merck KGaA Revenue in Mycoplasma Diagnostics Business (2015-2020)
13.5.5 Merck KGaA Recent Development
13.6 Lonza Group
13.6.1 Lonza Group Company Details
13.6.2 Lonza Group Business Overview
13.6.3 Lonza Group Mycoplasma Diagnostics Introduction
13.6.4 Lonza Group Revenue in Mycoplasma Diagnostics Business (2015-2020)
13.6.5 Lonza Group Recent Development
13.7 Takara Bio Inc (Takara Holding Company Inc.)
13.7.1 Takara Bio Inc (Takara Holding Company Inc.) Company Details
13.7.2 Takara Bio Inc (Takara Holding Company Inc.) Business Overview
13.7.3 Takara Bio Inc (Takara Holding Company Inc.) Mycoplasma Diagnostics Introduction
13.7.4 Takara Bio Inc (Takara Holding Company Inc.) Revenue in Mycoplasma Diagnostics Business (2015-2020)
13.7.5 Takara Bio Inc (Takara Holding Company Inc.) Recent Development
13.8 Savyon Diagnostics
13.8.1 Savyon Diagnostics Company Details
13.8.2 Savyon Diagnostics Business Overview
13.8.3 Savyon Diagnostics Mycoplasma Diagnostics Introduction
13.8.4 Savyon Diagnostics Revenue in Mycoplasma Diagnostics Business (2015-2020)
13.8.5 Savyon Diagnostics Recent Development
13.9 Tecan Trading AG (Tecan Group)
13.9.1 Tecan Trading AG (Tecan Group) Company Details
13.9.2 Tecan Trading AG (Tecan Group) Business Overview
13.9.3 Tecan Trading AG (Tecan Group) Mycoplasma Diagnostics Introduction
13.9.4 Tecan Trading AG (Tecan Group) Revenue in Mycoplasma Diagnostics Business (2015-2020)
13.9.5 Tecan Trading AG (Tecan Group) Recent Development
13.10 Sartorius Stedim BioOutsource Limited
13.10.1 Sartorius Stedim BioOutsource Limited Company Details
13.10.2 Sartorius Stedim BioOutsource Limited Business Overview
13.10.3 Sartorius Stedim BioOutsource Limited Mycoplasma Diagnostics Introduction
13.10.4 Sartorius Stedim BioOutsource Limited Revenue in Mycoplasma Diagnostics Business (2015-2020)
13.10.5 Sartorius Stedim BioOutsource Limited Recent Development
13.11 American Type Culture Collection (ATCC)
10.11.1 American Type Culture Collection (ATCC) Company Details
10.11.2 American Type Culture Collection (ATCC) Business Overview
10.11.3 American Type Culture Collection (ATCC) Mycoplasma Diagnostics Introduction
10.11.4 American Type Culture Collection (ATCC) Revenue in Mycoplasma Diagnostics Business (2015-2020)
10.11.5 American Type Culture Collection (ATCC) Recent Development
13.12 F Hoffmann-La Roche
10.12.1 F Hoffmann-La Roche Company Details
10.12.2 F Hoffmann-La Roche Business Overview
10.12.3 F Hoffmann-La Roche Mycoplasma Diagnostics Introduction
10.12.4 F Hoffmann-La Roche Revenue in Mycoplasma Diagnostics Business (2015-2020)
10.12.5 F Hoffmann-La Roche Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
